Chronic sclerosing sialadenitis
Chronic sclerosing sialadenitis (CSS) is a rare, chronic inflammatory disease that primarily affects the salivary glands, particularly the parotid gland. The condition is characterized by progressive fibrosis (scarring), inflammation, and hardening of the salivary glands.
Etiology[edit | edit source]
The exact cause of CSS is unknown. However, it is believed to be an autoimmune disease, where the body's immune system mistakenly attacks its own tissues. Some researchers suggest that it may be associated with IgG4-related disease, a systemic condition characterized by tumefactive lesions and often elevated serum IgG4 levels.
Clinical Presentation[edit | edit source]
Patients with CSS typically present with a firm, painless swelling of the salivary glands. The swelling is often unilateral and can progressively increase in size. Other symptoms may include xerostomia (dry mouth), dysphagia (difficulty swallowing), and recurrent salivary gland infections.
Diagnosis[edit | edit source]
Diagnosis of CSS is often challenging due to its rarity and non-specific symptoms. It is typically confirmed through a combination of clinical examination, imaging studies such as ultrasound or computed tomography (CT) scan, and histopathological examination of a biopsy specimen. The histopathological findings typically show dense lymphoplasmacytic infiltrate, fibrosis, and acinar atrophy.
Treatment[edit | edit source]
Treatment of CSS is primarily aimed at managing symptoms and preventing complications. This may include the use of corticosteroids to reduce inflammation, sialogogues to stimulate saliva production, and antibiotics to treat or prevent infections. In severe cases, surgical removal of the affected gland may be necessary.
Prognosis[edit | edit source]
The prognosis of CSS is generally good with appropriate management. However, the condition can significantly impact the patient's quality of life due to persistent symptoms and potential complications such as recurrent infections and sialolithiasis (salivary stones).
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD